Embleema Virtual Studies

An integrated Software-as-a-Service suite allowing investigators to rapidly design studies, generate on-the-fly easy to use patient apps to collect patient consent and study data, study coordinators to track in a single view each participant's enrollment and progress with the study, and data managers to curate the study data as it is gathered.

embleema | Study Designer

Design the informed patient consent, data collection and common data model per the study protocol in an easy to use, configuration based interface. Without any coding required, patient apps for iPhones and Android devices are generated on the fly and available to participants to get started.

embleema | Study Designer
embleema | Patient App

embleema | Patient App

This patient-centric app allows patients to provide their informed consent to the study in a clear, step-by-step, easy to understand fashion. Once their consent is given, study participants can respond to surveys, consolidate their electronic medical records from their care centers and their data from their wearable devices. The embleema patient app is designed to maintain sustainable engagement from participants who receive continuous feedback and insights from the study, as well as points that can be redeemed for rewards.

embleema | Study Coordinator

Study coordinators track each participant’s progress within the study and have an integrated, continuous view of the collected and missing data. An embleema Study Coordinator can also generate alerts to the study coordinator or the investigator when a participant’s generates data exceeding a predefined threshold (e.g. high scores on a depression survey).

 

embleema | Study Coordinator
embleema | Data Curator

embleema | Data Curator

Data managers can curate data as it is being gathered. A set of automated quality control algorithms allows data managers to quickly flag data issues and solve them. All data curation actions are registered in the embleema Blockchain, providing a robust data provenance audit-trail.

See us in Action

 

We are working with NYU Langone on the Human Epilepsy Project to help find a cure for a disease affecting over 2.4 million Americans

Learn More